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Background: Lipoprotein lipase (LPL) hydrolyzes triglycerides in lipoproteins and makes fatty acids available for
tissue metabolism. The activity of the enzyme is modulated in a tissue specific manner by interaction with other
proteins. We have studied how feeding/fasting and some related perturbations affect the expression, in rat adipose
tissue, of three such proteins, LMF1, an ER protein necessary for folding of LPL into its active dimeric form, the
endogenous LPL inhibitor ANGPTL4, and GPIHBP1, that transfers LPL across the endothelium.
Results: The system underwent moderate circadian oscillations, for LPL in phase with food intake, for ANGPTL4 and
GPIHBP1 in the opposite direction. Studies with cycloheximide showed that whereas LPL protein turns over rapidly,
ANGPTL4 protein turns over more slowly. Studies with the transcription blocker Actinomycin D showed that
transcripts for ANGPTL4 and GPIHBP1, but not LMF1 or LPL, turn over rapidly. When food was withdrawn the
expression of ANGPTL4 and GPIHBP1 increased rapidly, and LPL activity decreased. On re-feeding and after injection
of insulin the expression of ANGPTL4 and GPIHBP1 decreased rapidly, and LPL activity increased. In ANGPTL4−/−
mice adipose tissue LPL activity did not show these responses. In old, obese rats that showed signs of insulin
resistance, the responses of ANGPTL4 and GPIHBP1 mRNA and of LPL activity were severely blunted (at 26 weeks of
age) or almost abolished (at 52 weeks of age).
Conclusions: This study demonstrates directly that ANGPTL4 is necessary for rapid modulation of LPL activity in
adipose tissue. ANGPTL4 message levels responded very rapidly to changes in the nutritional state. LPL activity
always changed in the opposite direction. This did not happen in Angptl4−/− mice. GPIHBP1 message levels also
changed rapidly and in the same direction as ANGPTL4, i.e. increased on fasting when LPL activity decreased. This
was unexpected because GPIHBP1 is known to stabilize LPL. The plasticity of the LPL system is severely blunted or
completely lost in insulin resistant rats.
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Lipoprotein lipase (LPL) is produced by parenchymal cells
in some tissues (e.g. adipocytes, myocytes), secreted, and
transported to the luminal side of capillaries. Here the en-
zyme hydrolyzes triglycerides in chylomicrons and VLDL
and thereby makes fatty acids available for tissue metabo-
lism. LPL activity is rapidly modulated by the nutritional
state and plays a major role in distribution of fatty acids
between tissues [1,2] .
The rapid daily modulations of LPL activity are main-
ly post-transcriptional [1-3]. One mechanism involves
changes in the proportion of active to inactive species of
the enzyme without significant changes in total LPL pro-
tein [4]. Down-regulation of adipose tissue LPL activity
upon fasting requires that a gene, other than the LPL
gene, is switched on [5]. This implies a protein that can
transform LPL from an active to an inactive form.
The fasting-induced, PPAR-responsive angiopoietin-like
protein-4 (ANGPTL4) has emerged as a strong candi-
date for the role of such an LPL-controlling protein in
adipose tissue [6,7]. In vitro studies show that ANGPTL4
interacts with LPL and converts active LPL dimers to in-
active monomers [8,9]. Inactivation of Angptl4 in mice is
associated with low plasma triglycerides and high post-
heparin LPL activity [10]. A special case is that Angptl4−/−
mice on a diet with high content of saturated fat develop
severe abdominal inflammation due to excessive LPL-
mediated lipid uptake in mesenteric lymph nodes [11].
Similarly, a loss of function mutation in ANGPTL4 in
humans is associated with low levels of plasma triglycer-
ides [12]. Conversely, overexpression of Angptl4 in mice
results in low LPL activity and high plasma triglycerides
[10,13,14]. Taken together these data convincingly show
that ANGPTL4 is involved in modulating the activity of
LPL and thereby metabolism of plasma triglycerides. It
should be noted however that ANGPTL4 also has effects
on angiogenesis and several other processes, and that
there are additional members in the ANGPTL protein
family that have effects on plasma lipid metabolism [15] .
Another protein important for LPL action is the newly
discovered glycosylphosphatidylinositol-anchored high
density lipoprotein-binding protein 1, GPIHBP1 [16].
This protein, which is expressed only in endothelial cells,
is crucial for transfer of LPL to the luminal side of the
capillary endothelium [17]. Inactivation of the gene for
GPIHBP1 in mice results in gross chylomicronemia. Gen-
etic deficiency in humans produces a clinical phenotype
similar to that in LPL deficiency. It is not known if
GPIHBP1 has any direct role in the modulation of LPL ac-
tion. Like Angptl4 [6] the Gpihbp1 is PPAR-responsive [18],
suggesting that the two genes might be similarly regulated.
A third, newly discovered, protein involved with the
lipase system is the lipase maturation factor (LMF1).
This is an ER-based chaperone which appears to benecessary for maturation of LPL and the related hepatic
lipase and endothelial lipase into their active forms
[19,20].
In this paper we have explored how this landscape of
LPL controlling proteins behaves in rat adipose tissue
under a number of conditions previously shown to be
associated with rapid changes of LPL activity. Specifically
we have studied (1) if ANGPTL4 is needed for the rapid
modulation of LPL activity; (2) if the message levels show
circadian oscillations, (3) at what rates the messages for
the three LPL-controlling proteins and the proteins them-
selves are being turned over, (4) how the messages for the
LPL controlling proteins change on changes in the nutri-
tional state, known to cause large changes of adipose tis-
sue LPL activity and (5) what happens to the expression of
the three proteins when rats become insulin resistant.
Results
Circadian rhythm
The expressions in adipose tissue of many of the genes
involved in energy metabolism undergo circadian changes
[21]. We followed the changes with time of day of a num-
ber of parameters related to LPL activity (Figure 1). Rats
eat mainly during the dark period (18:00 h – 6:00 h). Mean
food consumption was 0.88 ± 0.10% of body weight per
hour during the night (Figure 1A). During the first hours of
the light period (6:00 h – 9:00 h) the rats ate 0.04 ± 0.01%
of body weight per hour. This is less than 5% of what they
ate per hour during the night. From 9:00 h −15:00 h food
consumption per hour was about one quarter of that du-
ring the dark period. During the last hours of the light
period, 15:00 h – 18:00 h, food consumption increased to
about half of that during the dark period.
The changes in plasma glucose and non-esterified fatty
acids (NEFA) over the day were moderate (Figure 1B). Adi-
pose tissue LPL mRNA (Figure 1C) showed its highest
value at 22:00 h. This was 2.8 fold higher than the lowest
value (at 10:00 h, p=0.028). Changes in GPIHBP1 mRNA
(Figure 1C) were modest and the tendency was opposite to
that for LPL mRNA, with higher values during the light
than during the dark period. The increase in ANGPTL4
mRNA during the light period was more pronounced com-
pared to GPIHBP1, but the levels were down again by
18.00 h. LPL activity (Figure 1D) in adipose tissue showed
its highest value at 2:00 h and its lowest value at 10:00 h
(p<0.01). The difference was about two-fold. LPL mass
(Figure 1D) followed a similar pattern, and the ratio bet-
ween LPL activity and mass (specific activity) did not
change significantly.
Response of the proteins studied and of LPL activity
when mRNA or protein synthesis was blocked
To directly study the turnover of the proteins involved,
cycloheximide was injected in rats to block synthesis of
Figure 1 Circadian changes. Groups of young rats (n=6) fed ad lib were sacrificed at the indicated times over a 24 hour period. Epididymal
adipose tissue and blood were taken for analyses. (A) Food consumption was measured in a separate group of rats over a 3-day period. These
data are expressed as % of body weight per hour. (B) Glucose concentration in blood (■) and NEFA concentration in plasma (s○). (C) mRNA
abundance for LPL (●), ANGPTL4 (■) and GPIHBP1 (▲) in epididymal adipose tissue. (D) LPL activity (●) and mass (■) in the adipose tissue.
Statistical comparisons were made against the values at 2:00 h.
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3 hours (Figure 2A). LPL mass, measured by ELISA
(Figure 2A), and estimated from Western blots (Figure 2D),
decreased at a similar rate as the activity. These data
are in line with earlier observations that the LPL pro-
tein turns over rapidly [22,23]. In contrast, ANGPTL4
protein showed bands of similar intensity on western
blots throughout the four hours studied (Figure 2E and F).
The pattern was the same when antibodies to the C-
terminal (Figure 2E) or N-terminal domain (Figure 2F) of
ANGPTL4 were used. Almost all of the protein was full
length (here 68 kDa compared to MW standards). With
antibodies to the C-terminal domain small amounts of a
45 kDa fragment was seen (Figure 2E), probably repre-
senting the fibrinogen-like domain of ANGPTL4. These
data show that the ANGPTL4 protein turns over relatively
slowly, much slower than the LPL protein. The turnover
of the GPIHBP1 and LMF1 proteins could not be studied
since suitable antibodies were not available.To directly study the turnover of the corresponding
messages, the transcription blocker actinomycin D (ActD)
was injected (Figure 2). Fasted rats were used since the
level of ANGPTL4 and GPIHBP1 messages in adipose tis-
sue are several-fold higher in the fasted than in the fed
state [6,18]. In concert with earlier studies [5], LPL activity
in adipose tissue rose from 340 ± 43 to 1225 ± 112 mU/g
in six hours after ActD (Figure 2B). The value for LPL
mRNA decreased by 8% by 4 h and by 33% by 6 h
(Figure 2C), but these changes did not reach statistical sig-
nificance. LPL mass as measured by the ELISA increased
by 40% (p<0.05) in 6 h. Consistent with these data, Western
blots showed that the level of LPL protein was essentially
stable over the six h studied (Figure 2G). These data con-
firm that the LPL transcript is relatively stable.
While LPL activity went up, mRNA levels for ANGPTL4,
GPIHBP1 and LMF1 were reduced by 93%, 75% and 29%
by six hours after ActD (Figure 2C). These results show
that the ANGPTL4 and GPIHBP1 transcripts are turned
Figure 2 Time courses for the effects of cycloheximide and actinomycin D. Young rats were fasted overnight and were then injected with
cycloheximide (CHX, panels A and D-F) or ActD (panels B, C and G-I) starting at 8:00 h. Groups of rats (n=5) were sacrificed at the indicated times over
a 4 or 6 hour period. Rats for the time 0 groups were not injected and were sacrificed within one hour from the start of the experiment. Epididymal
adipose tissue was taken for analyses. (A) LPL activity (●) and mass (■) after CHX. (B) LPL activity (●) and mass (■) after ActD (C) mRNA levels for
ANGPTL4 (■), GPIHBP1 (▲), LPL (●) and LMF1 (▼). mRNA was calculated relative to 18S mRNA. The value at time 0 was set to 1 and values at
following time points calculated relative to this. (D-I) Western blots of adipose tissue as labeled in the figure. The antibodies to C-terminal ANGPTL4
used in panels E and H recognize both full-length ANGPTL4 and the fibrinogen-like C-terminal domain. The antibodies to the N-terminal domain of
ANGPTL4, used in panels F and I, identifies the full-length protein but do not see the C-terminal domain.
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showed bands of similar intensity throughout the six hours
(Figure 2H and I). This pattern was the same when anti-
bodies to the C-terminal or N-terminal domain were used.
Almost all of the protein was full length but traces of a
45 kDa fragment were seen with the antibody specific for
the C-terminal domain of ANGPTL4. These data again
show that the ANGPTL4 protein turns over relatively
slowly.
Early response to food withdrawal
To study the early events in adaptation of the LPL sys-
tem in adipose tissue to fasting, food was withdrawn
from rats in the morning. At this time the animals ate
rather little (Figure 1A). Their stomachs were about half
full and emptied almost completely within two hours
after food was removed. Insulin (Figure 3A) and glu-
cose (Figure 3B) decreased whereas NEFA increased
(Figure 3B). Triglycerides decreased, presumably because
the inflow of chylomicrons from the intestine faded
(data not shown). LPL mRNA in adipose tissue did not
change significantly, in accordance with earlier observa-
tions [24] (data not shown). The level of mRNA for
LMF1 also did not change significantly (data not shown).In contrast, the levels of ANGPTL4 mRNA and GPIHBP1
mRNA increased markedly (about 6-fold and 2-fold,
respectively) in adipose tissue over the six hours studied
(Figure 3C). LPL activity in adipose tissue had decreased
by 40% at four hours and by 53% at six hours (Figure 3D).
In contrast there was no significant change of LPL mass
(Figure 3D). All of these responses to food withdrawal
were similar in a parallel experiment on female rats, but
data are shown only for males. These data indicate that
short term fasting is associated with reciprocal changes in
adipose ANGPTL4 mRNA and LPL activity.Relation to changes in expression of other genes
To get a perspective on the rapid and large response of
Angptl4 transcript on fasting [8] we carried out an array
analysis of the changes of RNA abundances in adipose
tissue under the conditions used for our experiments.
For this, food was removed from one group of rats in
the early morning. Seven h later the rats were sacrificed,
epididymal adipose tissue was cut out, RNA prepared
and analyzed on Illumina arrays. N = 6 for both the
fasted and the ad lib group. After filtering the data for P
< 0.01 and signal intensity > 50, there remained 22
Figure 3 Response to food deprivation. Food was withdrawn from young rats at 8:00 h. Animals were then sacrificed at the indicated time points
over a six hour period (n=6 at each time). The experiment was conducted over three days. Rats for the different time points were randomly included
on each day. Epididymal adipose tissue and blood were taken for analyses and the stomach with its content was cut out and weighed. (A) Weight of
the stomach expressed as fraction of body weight (●) and concentration of insulin in plasma (□) (B) Concentrations of glucose (■) and NEFA (○) in
blood and plasma, respectively (C) mRNA abundance for ANGPTL4 (■) and GPIHBP1 (▲). mRNA was calculated relative to 18S mRNA. The value at
time 0 was set to 1 and values at following time points were calculated relative to this. (D) LPL activity (●) and mass (■).
Table 1 The eight genes that increased their expression
in adipose tissue the most when food was removed










Food was removed from one group of rats in the early morning. Seven h later
the rats were sacrificed, epididymal adipose tissue was cut out, RNA prepared
and analyzed on Illumina arrays. N = 6 for both the fasted and the ad lib
group. Full data are deposited at NCBI GEO, accession no GSE 41800.
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by a factor of 2.0 or more.
Sorting by foldchange+, Angptl4 came out as number
four from the top (foldchange 3.37, p < E * 10
-17), preceded
only by Pdk4, pyruvate dehydrogenase kinase 4, a key
regulator of glycolysis/glyceroneogenesis, Gpr109a, the ke-
tone body/niacin receptor, a key regulator of lipolysis, and
RGD1565690_predicted, a gene of unknown function
(Table 1). In concert with the results of the experiment in
Figure 3 and earlier observations [24], the expression of
LPL did not change significantly (foldchange 1.02). Neither
Gpihbp1 or LmfF1 was represented on this chip.
Responses to re-feeding
To study a situation when adipose tissue LPL activity
increases rapidly we turned to re-feeding as a physio-
logical model that we had used before [8]. For this, rats
were fasted overnight and food was given back in the
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one hour their stomachs contained 2.0 ± 0.03 g/100 g body
weight (Figure 4A), similar to what was found in the sto-
mach of regularly fed rats (Figure 3A). Insulin (Figure 4A)
followed a time course similar to that for weight of sto-
mach contents. Glucose increased (Figure 4B), and NEFA
decreased (Figure 4B). ANGPTL4 and GPIHBP1 mRNA
levels decreased rapidly and after two hours were only 35
and 21% of the initial levels, respectively (Figure 4C). LPL
activity and mass increased (Figure 4D). Thus, similar to
fasting, fasting-refeeding is associated with reciprocal
changes in adipose ANGPTL4 and GPIHBP1 mRNA on
the one hand, and LPL activity on the other hand.
Response of the LPL system to fasting and re-feeding in
Angptl4 −/− mice
To directly investigate the role of ANGPTL4 in the rapid
modulation of LPL activity we turned to studies in mice inFigure 4 Responses to re-feeding. Young rats were fasted overnight (16
(n=5) were sacrificed after one or two hours. Time = 0 min were a group o
tissue and blood was collected and analyzed. The stomach was cut out, we
the “contents in stomach” and is expressed as fraction of body weight (A)
plasma (□) (B) Concentrations of glucose (■) and NEFA (○) in blood and p
GPIHBP1 (▲). mRNA was calculated relative to 18S mRNA. The value at tim
relative to this. (D) LPL activity (●) and mass (■).which Angptl4 had been inactivated [10]. Groups of mice
(n=6) were fed ad lib, fasted over night, or fasted over
night and then re-fed in the morning for 3 h. Plasma lipid
levels were in accordance with previous results on
Angptl4−/− mice [10]. Separation of lipoprotein classes by
FPLC high-lighted that the fasted Angptl4−/− mice had no
TG in the VLDL fraction, while after re-feeding the levels
of VLDL TG were similar in Angpt4−/− compared to wild-
type mice (Figure 5A). The peak of HDL cholesterol was
slightly higher in Angptl4−/− and was shifted towards larger
particles in all three groups of mice compared to wild-type
(Figure 5A). The increase in NEFA on fasting was blunted
in the Angptl4−/− mice (Figure 5B). This is in accordance
with a role of ANGPTL4 for intracellular lipolysis [25].
In the wild-type animals, fasting caused a decrease of
adipose tissue LPL activity, as expected (Figure 6A). In
contrast, fasting caused an increase of adipose tissue
LPL activity in the Angptl4−/− mice compared to fed orh, from 16:00 h). Food was given back (at 8:00) and groups of rats
f rats sacrificed within one h of continued fasting. Epididymal adipose
ighed, opened and rinsed and then weighed again. The difference is
Weight of contents in stomach (●) and concentration of insulin in
lasma, respectively. (C) mRNA abundance for ANGPTL4 (■) and
e 0 was set to 1 and values at following time points were calculated
Figure 5 Plasma lipids in Angptl−/− mice. Wild-type and Angptl−/− mice were fasted overnight or fed ad lib. Food was given back to groups of
fasted mice at 6:00 h (re-fed), while others continued fasting or eating (n=6 per group). All animals were sacrificed between 9:00 h – 10:00 h.
(A) FPLC analyses of pooled plasma samples representing the 6 different groups. (B) Fatty acids (NEFA) in individual plasma samples. Statistically
significant (p<0.05) differences are indicated by: a when comparing fasted or re-fed animals to ad lib for the same genotype b when comparing
the two genotypes for the same nutritional state.
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higher in all three nutritional states in Angptl4−/− com-
pared to wild-type animals, indicating that ANGPTL4
represses LPL activity to some extent also in fed animals.
ANGPTL4 mRNA was about two-fold increased in
fasted compared to ad lib fed wild-type mice, while, as
expected, there was no detectable ANGPTL4 mRNA in
the Angptl4−/− mice (Figure 6C). GPIHBP1 mRNA was
also increased about two-fold in fasted wild-type mice
compared to the fed groups. Interestingly, this difference
was not seen in the Angptl4−/− mice (Figure 6D). LPL
mRNA was not significantly changed in wild-type mice,
but was decreased in the fasted Angptl4−/− mice com-
pared to the fed groups (Figure 6B). Taken together
these data demonstrate that the reduction in adiposeLPL activity upon fasting is dependent on increased ex-
pression of ANGPTL4.
Response to insulin
To study direct effects of insulin on the LPL system,
fasted rats were given an intraperitoneal injection of in-
sulin, 1 U/kg body weight, which is in the range used for
insulin tolerance tests in rodents [26]. The injection
resulted in levels of insulin in blood that were about five
times higher than the mean level in controls at 60 min.
Glucose and NEFA both decreased (data not shown).
Already one hour after the injection, adipose tissue LPL
activity had almost doubled (Figure 7). LPL mass did not
change significantly (data not shown). ANGPTL4 and
GPIHBP1 mRNA both decreased (Figure 7). One hour
Figure 6 Response of the LPL system to fasting and re-feeding in Angptl4 −/− mice. Epididymal adipose tissue from the same mice as
described in Figure 5 was cut out and analyzed for LPL activity and mRNA abundance for LPL, ANGPTL4, and GPIHBP1. The levels of mRNA were
calculated relative to cyclophilin mRNA. Statistically significant (p < 0.05) differences are indicated by: a when comparing Angptl4−/− and WT for the
same nutritional state b when comparing fasted and ad lib for the same genotype c when comparing refed and ad lib for the same genotype.
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the initial levels, respectively.
Changes with age and/or weight of the rats
Previous studies have shown that the response of adipose
tissue LPL activity to feeding/fasting is blunted in old,
obese rats [5,27]. To probe this we studied rats at three
different ages, 5 weeks old, lean, body weight 199 ± 20 g;
25 weeks old, moderately obese, body weight 695 ± 66 g;
and 52 weeks old, grossly obese, body weight 1006 ± 82 g.
One set of rats from each age group was fasted overnight
and compared to ad lib fed controls.
In the fasted state, the young lean rats had low blood
glucose, about 3.3 mmol/L. The intermediate and old
rats had much higher blood glucose, about 6.0 mmol/L
(Figure 8A). In the fed state the three groups had similar
blood glucose levels, around 8 mmol/L. The fed/fasted
ratio for glucose was around 2.3 in the young, lean rats,
but only 1.3 and 1.2 in the old and intermediate groups,
respectively. NEFA levels were similar in all three groups
in the fed state (Figure 8B). On fasting, the level
increased almost three-fold in the young rats, but did
not change significantly in the intermediate or old rats.Plasma insulin levels (Figure 8C) showed large diffe-
rences between the groups. The fasting level was below
0.6 ng/ml in the young rats, four times higher in the
intermediate group and 12 times higher in the oldest
group. The fed/fasted ratio was about 5 in the young
lean rats, but only 1.35 in the intermediate group. In the
old group insulin levels in plasma did not differ between
fed or fasted animals.
In accordance with the observations for food with-
drawal (Figure 3) and re-feeding (Figure 4), ANGPTL4
and GPIHBP1 mRNA levels were much higher in the
fasted than in the fed state in the young rats (Figure 8D
and E). In contrast there were no statistically significant
changes with nutritional state in the older rats.
Adipose tissue LPL activity, expressed per gram wet
tissue weight, was high in the young rats, about
1600 mU/g. In the intermediate and old rats the activity
was less than one-third (Figure 8F). These rats had
much larger fat pads than the young lean ones so that
the total LPL activity per pad was actually larger in the
older groups (2.1-fold and 3.6-fold for the intermediate
and old rats, respectively), compared to the young rats.
Remarkably, the response to nutritional state was more
Figure 7 Effects of insulin on expression of LPL activity,
ANGPTL4 and GPIHBP1. Insulin was injected i.p. to young rats
fasted for 6 hours (from 8:00 h, n=6 per group). The rats were
sacrificed 60 min after injection. Time = 0 min were non-injected
rats sacrificed before the injected rats. LPL activity and mass and
mRNA abundance for ANGPTL4 and GPIHBP1 were measured in
epididymal adipose tissue.
Figure 8 Effects of age and/or obesity. Groups of rats of different ages (
fasted overnight for 16 h (open bars). At 8:00 h groups of fed and fasted ra
epididymal fat body was cut out and weighed. Blood was also taken for an
ANGPTL4 (D) and GPIHBP1 (E) and are expressed relative to 18S RNA. (F) LP
are made between fed and fasted animals. The numbers above some of th
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more than twice as high as that in the two older groups
(Figure 8F).
Discussion
The present study reinforces previous observations that
rapid modulation of LPL activity (in rodent adipose tis-
sue) is not exerted at the level of LPL gene expression
[1,24,27,28]. LPL mRNA levels remained essentially
stable under the conditions we tested. Likewise, the
mRNA for LMF1, an ER protein needed for proper ma-
turation of LPL into its active form [19,20], did not
change significantly, in accordance with an earlier study
in Zucker diabetic rats [29]. In contrast, the mRNAs for
ANGPTL4 and GPIHBP1, changed much more rapidly
than most mRNAs in mammalian cells [30]. These two
proteins interact with LPL and we will designate them
collectively as ‘LPL controlling proteins’. There may well
be more, yet undiscovered, proteins that participate in
the LPL system. A major mechanism for the modulation
of adipose LPL activity is conversion of catalytically ac-
tive LPL dimers into inactive monomers [4,8]. This
process is virtually irreversible [31,32]. The LPL protein,
active or inactive, turns over with a half-life of less than
two hours [22,23] which is much more rapid than the5 weeks, 26 weeks and 52 weeks) were either fed ad lib (solid bars) or
ts of the indicated age were sacrificed (n=5 per group). The
alyses of (A) glucose, (B) NEFA and (C) Insulin. mRNA levels for
L activity expressed per g wet weight of tissue. Statistical comparisons
e bars represent the relative change from the fasted to the fed state.
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Hence, the overall design of the LPL system appears to
be relatively constant production and secretion of short-
lived enzyme molecules that either retain or loose their
catalytic activity in response to a number of controlling
proteins. This design may have evolved to meet the need
to modulate the activity of secreted/extracellular LPL
molecules.
The expression of many genes involved in energy me-
tabolism undergo profound circadian oscillations in the
adipose tissue presumably to adapt the animal to pre-
dictable changes in the environment [21], LPL mRNA,
mass and activity all shoved higher values in the middle
of the dark period. For LPL activity the amplitude was
about two-fold, in accordance with previous studies
[24,33-37]. ANGPTL4 and GPIHBP1 mRNA showed
modest changes opposite in direction to that for LPL.
Hence, it appears that the LPL system displays a mode-
rate circadian oscillation in phase with the eating beha-
vior, but can respond rapidly and profoundly whenever
food becomes scarce. Of note, the circadian oscillations
of adipose tissue LPL are more pronounced in mice,
with a more than three-fold higher activity in the middle
of the dark period compared to the middle of the light
period [38]. A significant circadian variation has also been
reported for post-heparin LPL activity in humans [39].
A possible confounding factor for studies of how LPL
activity is modulated in adipose tissue is changes in the
rate at which proteins are being synthesized in the adi-
pocytes [1]. Parkin et al. found that insulin more than
doubled the rate of incorporation of amino acids into
proteins in rat fat pads and caused a corresponding in-
crease in LPL activity [40]. Other groups have reported
similar observations [1,2]. Kern and his associates have
described a more specific mechanism that affects LPL
synthesis whereby stimulation of the protein kinase A
system leads to formation of a protein complex that
binds to the 3’UTR of LPL mRNA and blocks its transla-
tion [28]. It seems likely that part of the early responses
of LPL activity in our studies, e.g. after injection of a large
dose of insulin, reflect decreased/increased rates of LPL
translation. This can not, however, fully explain the changes
seen. For instance, during food deprivation (Figure 3) LPL
activity decreased by more than 50%, while there was no
significant change in LPL mass.
The experiment on Angptl4−/− mice clearly demon-
strated the important role of ANGPTL4 for suppression
of adipose tissue LPL activity in the fasted state. Even
though LPL mRNA levels were significantly reduced in
adipose tissue of the Angptl4−/− mice, compared to all
other groups of mice, LPL activity was the highest in
adipose tissue of fasted Angptl4−/− mice. Also in the ad
lib fed and the re-fed states, adipose tissue LPL activity
was significantly higher in Angptl4−/− mice than in wild-type mice, indicating that some LPL is depressed by
ANGPTL4 even under conditions when LPL activity is
at demand. These data are compatible with those of
Köster et al. [10], demonstrating 2–3 fold higher LPL ac-
tivity in post-heparin plasma in Angptl4−/− mice com-
pared to wild-type mice in both fed and fasted animals.
Similarly, blocking transcription by ActD led to a de-
crease in ANGPTL4 mRNA levels in adipose tissue and
to a 3-fold increase in LPL activity in fasted rats [8], and
to a 3-fold increase in post-heparin plasma LPL activity
in ad lib fed rats [41]. In fed animals, most of the LPL
activity in post-heparin plasma originates from adipose
tissue, while in fasted animals the dominating source is
presumably skeletal muscle and heart [38,42]. Taken to-
gether the data demonstrate that ANGPTL4 is an im-
portant modulator of LPL activity in both fasted and fed
animals.
The present data show that ANGPTL4 mRNA turns
over rapidly in adipose tissue, in concert with an earlier
study [8]. When transcription was blocked by injection
of ActD, the mRNA decreased more than 90% in 4 hours.
The mRNA level responded rapidly to the perturbations
of the nutritional state that we used. It increased more
than 200% from 3 to 6 hours after food deprivation. It
decreased by about 50% in one hour after injection of in-
sulin and by about 65% within two hours after re-
feeding of rats that had fasted overnight. In all of these
situations, the expression of Angptl4 changed as
expected for a gene that negatively controls LPL activity.
Whenever the expression of Angptl4 increased, LPL
activity decreased and conversely when the expression
of Angptl4 decreased, LPL activity increased. The time
courses for the changes were compatible with a major
role for ANGPTL4 in modulation of LPL activity, if one
takes into account that the general rate of protein syn-
thesis, and hence LPL synthesis, probably changed (see
above). In contrast to the rapid changes of ANGPTL4
message levels, the ANGPTL4 protein remained essen-
tially unchanged over several hours, as evaluated by
Western blots. This was true whether we used anti-
bodies to the N-terminal or C-terminal domains, and
was true both in experiments where syntheses of new
protein was blocked by cycloheximide and in experi-
ments where message levels changed several-fold in res-
ponse to a transcription block or in response to food
withdrawal, re-feeding or insulin injection. This suggests
compartmentalization, such that only newly synthesized
ANGPTL4 protein can inactivate LPL. Within cells the
ANGPTL4 protein exists as monomers but they form
oligomers when they reach the cell surface [43]. It is
only after oligomerization that the ANGPTL4 protein
can interact with and inactivate LPL [12,43]. Hence, it is
possible that LPL and ANGPTL4 monomers do not
interact when they travel through the secretory pathway,
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the cell surface that triggers oligomerization of ANGPTL4
and thereby inactivation of LPL. LMF1 may have a role
here [20]. Once LPL transfers to the endothelial cells the
enzyme may be rescued by interaction with heparan sul-
fate proteoglycans [44] and/or GPIHBP1 [45].
The message for GPIHBP1 also turned over rapidly.
When transcription was blocked by ActD the message
decreased by more than 60% within 4 hours. It increased
4-fold from 3 to 6 hours after food deprivation. It
decreased by about 50% in one hour after injection of in-
sulin and by about 80% within 2 hours after re-feeding of
overnight fasted rats. This is in accordance with the stud-
ies of Davis et al. who found that GPIHBP1 message in
adipose tissue is higher in 16 h fasted than in fed rats [18].
Comparing the amplitudes of the changes, Gpihbp1 was
at least as responsive as Angptl4. This is impressive con-
sidering that array analysis showed that Angptl4 was one
of the genes whose expression had increased most seven
hours after food withdrawal (Table 1). The changes of
GPIHBP1 mRNA were in the same direction as the
changes of ANGPTL4 mRNA in all the situations that we
studied. This is surprising. According to present hypoth-
eses ANGPTL4 protein suppresses LPL activity. GPIHBP1
on the other hand stabilizes the enzyme and promotes its
delivery to the site of action at the vascular endothelium
[45]. One should note that the changes presumably take
place in different cells in the tissue. Gpihbp1 is expressed
in endothelial cells [16] whereas Angptl4 is presuma-
bly expressed mainly in adipocytes. It is possible that
GPIHBP1 not only delivers LPL to the luminal side of the
endothelium, but that under certain circumstances, like
during fasting, GPIHBP1 may predominantly transport
LPL in the opposite direction leading to LPL-inactivation
and or degradation within the tissue [46].
Rapid, tissue-specific modulation of LPL activity is im-
portant for whole body energy homeostasis by directing
lipid uptake to the appropriate tissues and limiting the
need for re-transport [1,2]. Earlier studies have shown
that the response of adipose tissue LPL activity to
feeding-fasting becomes blunted as rats grow older and
become obese [5,24]. The present study confirms these
observations and links them to the development of insu-
lin resistance. In young, lean rats (5 weeks old) adipose
tissue LPL activity decreased by a factor of 3.6 – 3.9 on
fasting overnight. In older, obese rats the response was
less than half, 1.7 – 1.9-fold. The older rats appeared to
be insulin-resistant. Fasting blood glucose and insulin
was elevated compared to the young rats and the diffe-
rence fed versus fasted was less for all parameters stu-
died. It is of interest to note that these rats were not
manipulated in any way but housed by normal routines
and fed chow ad lib [47]. The responses of the LPL con-
trolling genes, Angptl4 and Gpihbp1 were blunted. Thelarge change in GPIHBP1 mRNA (about 3-fold) seen
when young rats were fasted was completely abolished
in the older rats. For ANGPTL4 mRNA some response
remained but it was much less than in the young rats. It
is of interest to note that the values seen in either the
fed or fasted state in the older rats were similar to those
seen in fasted young rats. Hence, it appears that it was
the ability to down-regulate the expression in the fed
state that caused the loss of metabolic plasticity. In line
with this it was recently shown that mRNA of Angptl4
is upregulated in diabetic mice [48] whereas insulin
inhibited Angptl4 mRNA expression in 3 T3-L1 adipo-
cytes [49]. Moreover, FFA, which are increased in the
insulin-resistant state, were shown to upregulate mRNA
expression of Angptl4 in human adipocytes [50]. A study
on groups of human subjects (young, lean compared to
old, obese with or without diabetes type II) demon-
strated a blunting of the response of Angptl4 to feeding/
fasting in both groups of elderly individuals compared to
the young, while no effect was in this case seen on
GPIHBP1 expression [42]. Bergö et al. found that blocking
transcription by ActD (which relieves the suppression of
LPL activity) increased adipose tissue LPL activity several-
fold in fasted young rats, but had only a small effect in old,
obese rats [5]. These data are compatible with the hypoth-
esis that expressions of Angptl4 and/or Gpihbp1 are main
determinants for LPL activity in adipose tissue of rats.
Modulation of LPL activity is important for partitioning
of lipids between tissues in accordance with changes in
the metabolic situation [1,2]. It is becoming evident that
that modulation of LPL action occurs by interplay of se-
veral factors. The central player, the LPL enzyme, appears
to be produced at a relatively constant rate. The activity
and the distribution of the enzyme between the endothe-
lial cell surface and other places in the tissue are deter-
mined by LMF1, ANGPTLl4 and GPIHBP1 and perhaps
other proteins in a context dependent manner. In addition
LPL action is modulated by factors pertaining to the lipo-
protein substrate [1]. Apolipoprotein CII is a necessary
cofactor. Apolipoprotein CIII and other apolipoproteins
can suppress lipase action. In this case the action of the
enzyme is inhibited but not irreversibly lost.
Conclusions
The main conclusion from this study is that ANGPTL4
is necessary for the rapid modulation of LPL activity in
adipose tissue. ANGPTL4 message levels responded very
rapidly to changes in the nutritional state. LPL activity
always changed in the opposite direction. This did not
happen in Angptl4−/− mice. GPIHBP1 message levels
also changed rapidly and in the same direction as
ANGPTL4, i.e. increased on fasting when LPL activity
decreased. This was unexpected because GPIHBP1 is
known to stabilize LPL.
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ance, the responses of ANGPTL4 and GPIHBP1 mRNA
and of LPL activity were severely blunted (at 26 weeks
of age) or almost abolished (at 52 weeks of age). Hence,
the plasticity of the LPL system is severely blunted or
completely lost in insulin resistant rats.Methods
Animal procedures
Inbred male Sprague–Dawley rats weighing 150–210 g
were used, except in the exp on the effect of ageing/in-
sulin resistance in Figure 8. The rats were housed with
free access to a standard pellet diet and water in a 12-h
light cycle (6:00 h – 18:00 h). Experiments were, unless
otherwise stated, carried out with rats fed or fasted over-
night (food removed at 16:00 h) or fasted for 6 h (food
removed at 8:00 h). During fasting the rats were kept in
cages with a perforated floor to prevent coprophagia. In
experiments with re-feeding, rats were fasted overnight
and then food was given back at 8:00 h. The experiment
then continued for 2 h. The rats were killed by decapita-
tion. The fat depot studied was the epididymal. Tissues
were collected into Eppendorf tubes and immediately
frozen in liquid nitrogen. Blood samples to be analyzed
for LPL activity and metabolites were collected in EDTA
blood collection tubes (Sarstedt). Plasma was obtained
by centrifugation of the blood at 4°C and the samples
were then stored at −70°C. the bars represent the relative
change from the fasted to the fed state
Male pure-bred WT and Angptl4−/− mice on a C57Bl/6
background between ages 4–6 months were used [10].
Fasted mice were fasted from 15:00 h and sacrificed the
next day between 9:00 h and 10:00 h. Refed mice were
fasted from 15:00 h, refed with chow the next day at
6:00 h and sacrificed between 9:00 h and 10:00 h. Mice
were anaesthetized with a mixture of isoflurane (1.5%), ni-
trous oxide (70%) and oxygen (30%). Blood was collected
by orbital puncture into EDTA tubes. Mice were killed by
cervical dislocation, after which tissues were excised and
directly frozen in liquid nitrogen.
All animal procedures were approved by the local ani-
mal ethics committees in Umeå (rats) and Wageningen
(mice), respectively.
In experiments on rats, insulin (Actrapid, Novo Nordisk
A/S, Denmark) was injected intraperitoneally (1U/kg bw)
to rats fasted for 6 h. Controls were injected with saline
only. Actinomycin D (Sigma Aldrich), dissolved in pure
ethanol to a concentration of 2 mg/ml, was injected intra-
peritoneally (2 mg/kg bw) to rats fasted for 6 h. Controls
were injected with ethanol. Cycloheximide (Sigma
Aldrich), dissolved in saline to a concentration of 35 mg/
ml, was injected intraperitoneally (35 mg/kg bw) to rats
fasted for 16 h. Controls were injected with saline.LPL activity assay
Frozen tissues were homogenized in 9 volumes of buffer at
pH 8.2 containing 0.025 M ammonia, 1% Triton X-100,
0.1% SDS and protease inhibitor cocktail tablets (Complete
Mini, Roche Diagnosis, Germany) using a Polytron PT
3000 Homogenizer (Kinematica). The homogenates
were centrifuged for 15 min at 10,000 rpm, 4°C. Aliquots
of the supernatants were used for determination of LPL
activity as previously described [5] using a phospholipid-
stabilized emulsion of soy bean triacylglycerols and 3H-
oleic acid-labeled triolein with the same composition as
Intralipid 10% (Fresenius Kabi, Uppsala, Sweden). The in-
cubation was at 25°C for 100 or 120 min. One milliunit of
enzyme activity corresponds to 1 nmol of fatty acids
released per min. Enzyme activity is expressed per g wet
tissue weight. In the exp in Figure 8 LPL activity per whole
epididymal fat pad was also calculated. All samples were
assayed in triplicates.
LPL mass determination
Mass was measured by an Elisa method previously
described [4,5]. Affinity purified immunoglobulins (IgY)
from chicken, raised against bovine LPL were used for
capture of the antigen during an overnight incubation.
Bound LPL was detected with 5D2 monoclonal antibody
raised against bovine LPL (a generous gift from Prof. J.
Brunzell, University of Washington, Seattle WA), followed
by detection with peroxidise-labelled anti-mouse IgG. LPL
purified from bovine milk was used as standard.Quantitative RT-PCR analyses
For determination of the levels of LPL, ANGPTL4,
GPIHBP1 and LMF1 mRNA in rat tissues, total RNA
was extracted from adipose tissues using TRIzol reagent
(Life Technologies) and treated with DNA-free kit
(Ambion). cDNA was prepared from 50 ng total RNA
using Moloney Murine Leukemia Virus Reverse Tran-
scriptase, RNase H Minus (Fermentas) and pd(N)6
Random Hexamer (Fermentas) in total volume of 20 μl.
The expression of the genes of interest were quantified
by real time PCR using TaqMan Universal PCR Master
Mix and the ABI Prism 7700 Sequence Detection Sys-
tem (Applied Biosystems, Foster City, CA) and normal-
ized to endogenous control (18S rRNA). ANGPTL4, LPL,
GPIHBP1 and LMF1 primers and probes were designed
from the published sequences for rat ANGPTLl4, LPL,
GPIHBP1 and LMF-1 (corresponding GenBank accession
numbers are: NM_199115, NM_000237, NM_001130547,
and XM_340769. The sequences for primers and probes
used were as follows:
50-Fam-CTTGGAGCCCATGCTGCTGGC-TAMRA
(LPL probe)























Expression levels were normalized to 18S rRNA using
the Eukaryotic18S rRNA Endogenous Control Reagent
Set supplied from Applied Biosystems. All calculation
was done in accordance with recommendation from Ap-
plied Biosystems (User Bulletin #2).
For analyses of mRNAs for LPL, GPIHBP1 and
ANGPTL4 in mouse adipose tissue, total RNA was isolated
with TRIzol reagent (Invitrogen, Breda, The Netherlands)
according to manufacturer’s instructions. One μg of to-
tal RNA was reverse transcribed using iScript (Bio-Rad,
Veenendaal, The Netherlands). cDNA was amplified on a
Bio-Rad CFX384 Real Time System using Sensimix (Bio-
line, GC Biotech, Alphen aan de Rijn, The Netherlands).
Cyclophilin was used as housekeeping gene. PCR primer
sequences were taken from the PrimerBank and ordered
from Eurogentec (Seraing, Belgium). Sequences of the pri-
mers used are available upon request.
Gene expression array
Food was removed from one group of rats (n=6) at 1:30 h
while another group (n=6) remained fed ad lib. The ani-
mals were killed starting from 8:15 h and epididymal adi-
pose tissue was collected. Aliquots of total RNA were
converted to biotinylated double-stranded cRNA using
Illumina Totalprep RNA Amplification Kit according to
manufacturer’s instructions (Ambion, Austin, TX, USA).
The labeled cRNA samples were hybridized to RatRef-12
Expression BeadChip (Illumina, San Diego, CA, USA),
incubated with streptavidin-Cy3 and scanned on the
Illumina Beadstation GX (Illumina, San Diego, CA, USA).
To determine differentially expressed genes microarraydata were analyzed using Illumina Beadstudio software
(version 3.3). The data were normalized and significant
differential expression was calculated using Beadstudio’s
cubic spline algorithm. False discovery rate was applied.
The gene expression fold change for the fasted group was
calculated as the average signal value relative to the aver-
age signal value for the ad lib fed group. Statistical signifi-
cance cutoff was set to P < 0.01; minimum signal intensity
was set at 50 A. Full data are deposited at NCBI GEO, ac-
cession no GSE41800.
Western analyses
The same homogenates as prepared for assay of LPL
activity and mass were used. Protein was determined by
the BDH protein assay (Pierce) and 20 μg of total pro-
tein was separated on 4-20% Tris-glycine gradient gels
(Lonza), and blotted onto PVDF membranes (Hybone-C,
Amersham Biosciences). The membranes were blocked by
ECL Advance blocking agent (GE Healthcare). For detec-
tion of LPL we used a rabbit polyclonal antibody from
Santa Cruz Biotechnology at a dilution of 1:2000. For de-
tection of ANGPTL4 we used a polyclonal goat anti-
human antibody against the N-terminal domain (N-15,
Santa Cruz Biotechnology), a goat polyclonal anti-mouse
against the C-terminal domain (L-17, Santa Cruz Biotech-
nology) and a rabbit polyclonal antibody against full-length
ANGPTL4 from Abcam, Cambridge, UK. All of these anti-
bodies were used at a dilution of 1:3000. For detection we
used the ECL detection system (GE Healthcare).
Metabolite assessments and plasma lipid profiles
For rats, NEFA-HR (WAKO Chemicals, Germany) was
used for measurements of plasma NEFA. Plasma insulin
was measured using coated plates from Mercodia, Sweden.
Trig/GB (Roche Diagnostics, Germany) was used for TG
measurements. One Touch Ultra (Life Scan, Milpitas, CA)
glucose sticks were used for blood glucose determinations
on whole blood immediately after collection.
For mice, plasma cholesterol was determined using the
Cholesterol PAP SL kit from Elitech (Sopachem, Ochten,
Netherlands). Plasma triglycerides were determined using
the GPO PAP kit from Instruchemie (Delfzijl, Netherlands).
Plasma lipoproteins were separated using fast protein liquid
chromatography (FPLC). For this 0.2 ml of pooled plasma
was injected into a Superose 6B 10/300 column (GE
Healthcare Bio-Sciences AB, Roosendaal, Netherlands) and
eluted at a constant flow of 0.5 ml/minute with phosphate
buffered saline (pH 7.4). The effluent was collected in
0.5 ml fractions and TG and cholesterol levels were
determined.
Statistical analysis
Data are presented as mean ± SEM. Statistical analyses
were performed using unpaired t-test of variances or
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*** = p<0.001. Unless otherwise stated, comparisons
were made to time = 0 min or to matched controls.
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